Assessing pathway biology is a complex and ever growing part of the lead discovery process. Invitrogen has the tools and the expertise to help advance your Lead discovery. We provide solutions to help analyze key signal transduction pathways in record time with our CellSensorCell Based assays, LanthaScreen Cellular Assays, and Stealth RNAi Collections.
|Analyze drug discovery-related pathways and disease-associated genes using our real-time PCR arrays, which feature TaqMan primer/probe sets in a 96-well or 384-well format. Alternatively, analyze individual drug discovery-related genes with TaqMan® primer/probe sets for detection of gene expression, or for genotyping of drug metabolizing enzyme (DME) and drug transporter polymorphisms.|
|Learn more about:|